BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications > Year 2016
Year 2016
  •   Q. Zhu et al., Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy. Scientific Reports (2016) 6.
  •   P. Zhang et al., Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel. ACS Nano (2016) 10, 3637.
  •   L. T. Wang et al., Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage. Cancer Research (2016) 76, 6631.
  •   Q. Li et al., A Naturally Derived, Growth Factor-Binding Polysaccharide for Therapeutic Angiogenesis. Acs Macro Letters (2016) 5, 617.
  •   Z. Huang et al., Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection. Biomaterials (2016) 90, 72.
  •   W. He et al., Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy. Scientific Reports (2016) 6.
  •   H. Ding et al., Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease. Parkinsonism Relat Disord (2016) 22, 68.
  •   T. T. Chen et al., Gua Sha, a press-stroke treatment of the skin, boosts the immune response to intradermal vaccination. Peerj (2016) 4.
  •   MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.Sun, X., S. Zhao, H. Li, H. Chang, Z. Huang, Z. Ding, L. Dong, J. Chen, Y. Zang and J. Zhang.2017; J Cell Physiol.232(3): 625-634.
  •   MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma. Wang C., X. Ba, Y. Guo, D. Sun, H. Jiang, W. Li, Z. Huang, G. Zhou, S. Wu, J. Zhang and J. Chen. Sci Rep. 2017; 7: 41456.
  •   The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Shi T., Y. Xie, Y. Fu, Q. Zhou, Z. Ma, J. Ma, Z. Huang, J. Zhang and J. Chen. Mucosal Immunol. 2016.
  •   Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease. Ding H., Z. Huang, M. Chen, C. Wang, X. Chen, J. Chen and J. Zhang. Parkinsonism Relat Disord. 2016; 22: 68-73.
  •   Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel. Zhang P., C. Wang, J. Zhao, A. Xiao, Q. Shen, L. Li, J. Li, J. Zhang, Q. Min, J. Chen, H. Y. Chen and J. J. Zhu. ACS Nano. 2016; 10 (3): 3637-47.
  •   Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage. Wang L., Q. Chen, H. Qi, C. Wang, C. Wang, J. Zhang and L. Dong. Cancer Res. 2016; 76 (22): 6631-6642.
  •   A Naturally Derived, Growth Factor-Binding Polysaccharide for Therapeutic Angiogenesis. Li Q., G. W. Guo, F. C. Meng, H. H. Wang, Y. M. Niu, Q. W. Zhang, J. F. Zhang, Y. T. Wang, L. Dong and C. M. Wang. Acs Macro Letters. 2016; 5 (5): 617-621
  •   Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy. Zhu Q., H. Qi, Z. Long, S. Liu, Z. Huang, J. Zhang, C. Wang and L. Dong. Sci Rep. 2016; 6: 28596.
  •   MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.Sun, X., S. Zhao, H. Li, H. Chang, Z. Huang, Z. Ding, L. Dong, J. Chen, Y. Zang and J. Zhang.2017; J Cell Physiol.232(3): 625-634.
  •   MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma. Wang C., X. Ba, Y. Guo, D. Sun, H. Jiang, W. Li, Z. Huang, G. Zhou, S. Wu, J. Zhang and J. Chen. Sci Rep. 2017; 7: 41456.
  •   The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Shi T., Y. Xie, Y. Fu, Q. Zhou, Z. Ma, J. Ma, Z. Huang, J. Zhang and J. Chen. Mucosal Immunol. 2016.
  •   Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease. Ding H., Z. Huang, M. Chen, C. Wang, X. Chen, J. Chen and J. Zhang. Parkinsonism Relat Disord. 2016; 22: 68-73.